NR1I2 and inflammatory bowel disease: Some researchers found that bacterial tryptophan metabolites such as IPA and 3-indoleacetic acid can activate aromatic hydrocarbon receptors or pregnane X receptor (PXR, an IBD therapeutic target) transcription factors to play an important protective and anti-inflammatory role in the gut by affecting interleukin-22 secretion [51].